Cargando…
Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
Dendritic cells (DCs) are the most important antigen-presenting cells that determine cancer immune responses by regulating immune activation and tolerance, especially in the initiation stage of specific responses. Manipulation of DCs to enhance specific antitumor immune response is considered to be...
Autores principales: | Qian, Chen, Yang, Li-Jun, Cui, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338589/ https://www.ncbi.nlm.nih.gov/pubmed/32694998 http://dx.doi.org/10.3389/fphar.2020.00960 |
Ejemplares similares
-
Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy
por: Zhou, Xuyan, et al.
Publicado: (2022) -
Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
por: Liu, Zhaoyuan, et al.
Publicado: (2021) -
Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer
por: Zhang, Chengyuan, et al.
Publicado: (2022) -
Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview
por: Alshememry, Abdullah K., et al.
Publicado: (2022) -
Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
por: Tang, Lin, et al.
Publicado: (2022)